108 related articles for article (PubMed ID: 1772973)
1. Target cells for immunomodulatory action of muramyl dipeptide.
Dozmorov IM; Bagaeva LV; Kuzin II; Svirshchevskaya EV
Biomed Sci; 1991; 2(2):193-7. PubMed ID: 1772973
[TBL] [Abstract][Full Text] [Related]
2. Immunological activities of muramyl peptides.
Bahr GM; Chedid L
Fed Proc; 1986 Oct; 45(11):2541-4. PubMed ID: 3489642
[TBL] [Abstract][Full Text] [Related]
3. [Muramyl dipeptide (MDP): its origin, mechanism of action and prospects for its use].
Castrillón LE
Salud Publica Mex; 1987; 29(6):492-9. PubMed ID: 3125614
[No Abstract] [Full Text] [Related]
4. [The stimulating action of lipopolysaccharide and muramyl dipeptide on the activation of mononuclear cells in human peripheral blood by recombinant interleukin-2 in vitro].
Rakhmilevich AL; Pelevina MA; Artsimovich NG; Fuks BB
Biull Eksp Biol Med; 1988 Dec; 106(12):698-701. PubMed ID: 3061497
[TBL] [Abstract][Full Text] [Related]
5. Demonstration of muramyl dipeptide (MDP)-induced T suppressor cells responsible for MDP immunosuppressive activity.
Leclerc C; Bourgeois E; Chedid L
Eur J Immunol; 1982 Mar; 12(3):249-52. PubMed ID: 6980118
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of human IL 2 production by MDP and derivatives.
Leclerc C; Morin A; Deriaud E; Chedid L
J Immunol; 1984 Oct; 133(4):1996-2000. PubMed ID: 6332144
[TBL] [Abstract][Full Text] [Related]
7. N-[trans-2-[[2'-(acetylamino)cyclohexyl]oxy]acetyl]-L-alanyl-D-glutamic acid: a novel immunologically active carbocyclic muramyl dipeptide analogue.
Kikelj D; Pecar S; Kotnik V; Stalc A; Wraber-Herzog B; Simcic S; Ihan A; Klamfer L; Povsic L; Grahek R; Suhadolc E; Hocevar M; Hönig H; Rogi-Kohlenprath R
J Med Chem; 1998 Feb; 41(4):530-9. PubMed ID: 9484503
[TBL] [Abstract][Full Text] [Related]
8. Production of and response to interleukin-2 by cultured T cells: effects of lithium chloride and other putative modulators.
Kishter S; Hoffman FA; Pizzo PA
J Biol Response Mod; 1985 Apr; 4(2):185-94. PubMed ID: 2987421
[TBL] [Abstract][Full Text] [Related]
9. Production of colony-stimulating factor from macrophages by muroctasin.
Yamaguchi F; Akahane K; Takashi T; Tsukada W
Arzneimittelforschung; 1988 Jul; 38(7A):983-6. PubMed ID: 3263870
[TBL] [Abstract][Full Text] [Related]
10. Muramyl dipeptide-Lys stimulates the function of human dendritic cells.
Todate A; Suda T; Kuwata H; Chida K; Nakamura H
J Leukoc Biol; 2001 Nov; 70(5):723-9. PubMed ID: 11698491
[TBL] [Abstract][Full Text] [Related]
11. Regulation by muramyl dipeptide (MDP) of the lymphoproliferative responses and polyclonal activation of human peripheral blood mononuclear cells.
Bahr GM; Modabber FZ; Morin A; Terrier M; Eyquem A; Chedid L
Clin Exp Immunol; 1984 Jul; 57(1):178-86. PubMed ID: 6744667
[TBL] [Abstract][Full Text] [Related]
12. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of alkaline phosphatase activity in stimulated B lymphocytes by muramyl dipeptide.
Souvannavong V; Adam A
Immunol Lett; 1990 Jul; 24(4):247-51. PubMed ID: 2391133
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of tumour necrosis factor production and sensitivity to interleukin-2 of human peripheral blood mononuclear cells stimulated by lipopolysaccharide and muramyl dipeptide in vitro.
Rakhmilevich AL; Shneiderova MA; Korobko VG; Chuvpilo SA
Biomed Sci; 1990; 1(5):517-23. PubMed ID: 2133069
[TBL] [Abstract][Full Text] [Related]
15. Human B lymphoblastoid cell lines provide an interleukin 1-like signal for mitogen-treated T lymphocytes via direct cell contact.
Arnold A; Lipkowitz S; Suthanthiran M; Novogrodsky A; Stenzel KH
J Immunol; 1985 Jun; 134(6):3876-81. PubMed ID: 2985701
[TBL] [Abstract][Full Text] [Related]
16. The same cloned murine B lymphoma cell lines can be selectively induced to release either interleukin-1- or interleukin-2-like factor activity.
Walker EB; Leemhuis T
Lymphokine Res; 1987; 6(2):71-81. PubMed ID: 3495708
[TBL] [Abstract][Full Text] [Related]
17. A novel immunostimulator, N-[alpha-O-benzyl-N-(acetylmuramyl)-L-alanyl-D-isoglutaminyl]-N6-trans-(m-nitrocinnamoyl)-L-lysine, and its adjuvancy on the hepatitis B surface antigen.
Yang HZ; Xu S; Liao XY; Zhang SD; Liang ZL; Liu BH; Bai JY; Jiang C; Ding J; Cheng GF; Liu G
J Med Chem; 2005 Aug; 48(16):5112-22. PubMed ID: 16078831
[TBL] [Abstract][Full Text] [Related]
18. Human recombinant IL-3 stimulates B cell differentiation.
Tadmori W; Feingersh D; Clark SC; Choi YS
J Immunol; 1989 Mar; 142(6):1950-5. PubMed ID: 2784144
[TBL] [Abstract][Full Text] [Related]
19. T cell-induced expression of membrane IgG by 70Z/3 B cells.
Jacobs DH; Sneller MC; Misplon JA; Edison LJ; Kunimoto DY; Strober W
J Immunol; 1986 Jul; 137(1):55-60. PubMed ID: 3086458
[TBL] [Abstract][Full Text] [Related]
20. Reversal of T cell anergy in leprosy patients: in vitro presentation with Mycobacterium leprae antigens using murabutide and Trat peptide in liposomal delivery.
Sridevi K; Khanna N; Chattree V; Pal PC; Haq W; Rao DN
Int Immunopharmacol; 2003 Nov; 3(12):1589-600. PubMed ID: 14555284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
